Daily Journal Staff Writer
President Barack Obama went after patented drugs not just once, but twice, to cut billions of dollars in his fiscal 2011 federal budget proposal.
Both initiatives - to end patent settlements between pharmaceutical and generic companies, and to shorten the period competitors must wait to sell generic biologic drugs - could bring generic medications to market sooner, saving money for government health ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In